Share Hutch News

Tissue samples from a landmark clinical trial conducted decades ago by the late Dr. Joel Meyers yield new insights and treatments

Infectious disease physician-researcher Dr. Steve Pergam is recognized for exceptional medical care and compassion to transplant patients and families.

Every year since its inception in the early 1980s, the Fred Hutch Long-term Follow-up Program sends out a detailed questionnaire to every transplant survivor. The answers to these questions inform a host of research topics on the long-term effects of transplantation, from graft-vs.-host disease to cataracts, from secondary cancers to infertility and sexual dysfunction.

For the fifth year in a row, the Fred Hutch Bone Marrow Transplant Program at Seattle Cancer Care Alliance has been recognized by the Center for International Blood and Marrow Transplant Research as exceeding expectations for one-year survival rates. These survival rates specifically pertain to patients who have received transplants of blood-forming stem cells from healthy donors, a procedure pioneered at Fred Hutch.

From gourmet dining to a VIP after-party with a surprise Hollywood star, Fred Hutch's 42nd annual signature fundraising event was a big party with a big goal: advancing research to save lives from cancer.

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases